香港電視(01137.HK)先舊後新配售9000萬股 淨籌約4.531億港元
格隆匯2月12日丨香港電視(01137.HK)公佈,於2月11日,公司(i)與賣方及UBS訂立配售協議;及(ii)與賣方訂立認購協議。
根據配售協議,UBS擔任賣方的獨家配售代理,促使承配人按配售價每股5.15港元(較收市價每股6.01港元折讓約14.31%)認購9000萬股現有股份。
根據認購協議,賣方認購9000萬股新股份,相當於配售協議及認購協議日期公司已發行股本約10.96%及經擴大公司已發行股本約9.88%。
據悉,認購事項所得款項淨額將約為4.531億港元。根據認購事項將籌得的資金擬用作(1)擴展集團電子商貿及有關業務;及(2)一般營運資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.